| Bioactivity | Tyr3-Octreotate acetate is a somatostatin analog. Tyr3-Octreotate acetate exhibits high uptake into tumor, that is capable to be labeled with radioactive metal and thus exhibits antitumor efficacy. Tyr3-Octreotate acetate can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs)[1]. | ||||||
| Sequence | {d-Phe}-Cys-Tyr-{d-Trp}-Lys-Thr-Cys-Thr (Disulfide bridge: Cys2-Cys7) | ||||||
| Shortening | {d-Phe}-CY-{d-Trp}-KTCT (Disulfide bridge: Cys2-Cys7) | ||||||
| Formula | C53H72N10O16S2 | ||||||
| Molar Mass | 1169.33 | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
| Reference | [1]. Capello A, et al., Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro. Cancer Biother Radiopharm. 2003 Oct;18(5):761-8. |
Tyr3-Octreotate acetate
CAS: F: C53H72N10O16S2 W: 1169.33
Tyr3-Octreotate acetate is a somatostatin analog. Tyr3-Octreotate acetate exhibits high uptake into tumor, that is capab
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.